Boosting Tumor-Specific Immunity Using PDT
暂无分享,去创建一个
[1] Erica G. Schmitt,et al. Generation and Function of Induced Regulatory T Cells , 2013, Front. Immunol..
[2] Paola Taroni,et al. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.
[3] K. Podsypanina,et al. How Numbers, Nature, and Immune Status of Foxp3+ Regulatory T-Cells Shape the Early Immunological Events in Tumor Development , 2013, Front. Immunol..
[4] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[5] M. Korbelik. Cancer vaccines generated by photodynamic therapy , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[6] B. Henderson,et al. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.
[7] M. Manns,et al. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo , 2003, International journal of cancer.
[8] Abhishek D. Garg,et al. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma , 2016, Science Translational Medicine.
[9] M. Korbelik,et al. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. , 2002, Cancer letters.
[10] R. Weissleder,et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Korbelik,et al. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.
[12] W. Sluiter,et al. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. , 1997, Cancer research.
[13] H. S. de Bruijn,et al. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.
[14] N. Restifo,et al. The interplay of effector and regulatory T cells in cancer. , 2015, Current opinion in immunology.
[15] T. Dougherty. An update on photodynamic therapy applications. , 2002, Journal of clinical laser medicine & surgery.
[16] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[17] P. Agostinis,et al. Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy , 2014, Oncoimmunology.
[18] Michael R Hamblin,et al. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model , 2008, Proceedings of the National Academy of Sciences.
[19] D. Vignali,et al. How regulatory T cells work , 2008, Nature Reviews Immunology.
[20] P. Mróz,et al. Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells , 2004, Clinical Cancer Research.
[21] Siyu Chen,et al. Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy , 2016, International journal of biological sciences.
[22] M. Korbelik,et al. Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[23] V. Kalia,et al. Quiescence of Memory CD8(+) T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4. , 2015, Immunity.
[24] T. Mak,et al. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.
[25] Barbara W. Henderson,et al. Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.
[26] A. Rudensky,et al. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.
[27] K. Knutson,et al. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy , 2005, Cancer Immunology, Immunotherapy.
[28] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[29] S. Gollnick,et al. Photodynamic therapy enhancement of anti-tumor immunity , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[30] L. Arnaut,et al. Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimens. , 2015, European journal of cancer.
[31] S. Gollnick,et al. Enhancement of anti-tumor immunity by photodynamic therapy , 2010, Immunologic research.
[32] A. Goetz,et al. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. , 1995, Cancer research.
[33] Michael R Hamblin,et al. Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response , 2010, PloS one.
[34] B. Krammer,et al. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma. , 2011, Photodiagnosis and photodynamic therapy.
[35] A. Oseroff,et al. Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy , 2009, Clinical Cancer Research.
[36] Michael R Hamblin,et al. Stimulation of anti-tumor immunity by photodynamic therapy , 2011, Expert review of clinical immunology.
[37] M. Manns,et al. Peptidases released by necrotic cells control CD8+ T cell cross-priming. , 2013, The Journal of clinical investigation.
[38] B. Boehm,et al. T Cell Immunity Induced by Live, Necrotic, and Apoptotic Tumor Cells1 , 2004, The Journal of Immunology.
[39] R. Graham,et al. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer. , 2014, The Journal of surgical research.
[40] Claudio H. Sibata,et al. Oncologic photodynamic therapy photosensitizers: a clinical review. , 2010, Photodiagnosis and photodynamic therapy.
[41] Malini Olivo,et al. Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. , 2007, The Lancet. Oncology.
[42] B. Henderson,et al. Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling , 2007, British Journal of Cancer.
[43] M. Strioga,et al. Dendritic cells and their role in tumor immunosurveillance , 2013, Innate immunity.
[44] S. Gollnick,et al. IL-17 Promotes Neutrophil Entry into Tumor-Draining Lymph Nodes following Induction of Sterile Inflammation , 2013, The Journal of Immunology.
[45] Mladen Korbelik,et al. PDT‐associated host response and its role in the therapy outcome , 2006, Lasers in surgery and medicine.
[46] M. Baptista,et al. Photodynamic Efficiency: From Molecular Photochemistry to Cell Death , 2015, International journal of molecular sciences.
[47] R. Steinman,et al. Dendritic Cells Charged with Apoptotic Tumor Cells Induce Long-Lived Protective CD4+ and CD8+ T Cell Immunity against B16 Melanoma 1 , 2003, The Journal of Immunology.
[48] Brigitta Stockinger,et al. Differentiation and function of Th17 T cells. , 2007, Current opinion in immunology.
[49] M. Beyer,et al. Regulatory T cells in cancer. , 2006, Blood.
[50] T. Nomura,et al. Regulatory T Cells and Immune Tolerance , 2008, Cell.
[51] J. Krosl,et al. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.
[52] G Corbitt,et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. , 2001, Cancer research.
[53] K. Awazu,et al. Photodynamic therapy induces interleukin secretion from dendritic cells. , 2010, International journal of clinical and experimental medicine.
[54] C. Langner,et al. Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma , 2014, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[55] Barbara W Henderson,et al. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. , 2007, Cancer research.
[56] Michael R Hamblin,et al. 5-Aza-2'-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy. , 2014, European journal of cancer.
[57] S. Sakaguchi,et al. Regulatory T cells – a brief history and perspective , 2007, European journal of immunology.
[58] M. Olivo,et al. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer , 2006 .
[59] François Guillemin,et al. Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies. , 2014, Cancer treatment reviews.
[60] F. Fox,et al. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. , 1998, The Journal of investigative dermatology.
[61] J. Levy,et al. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. , 1999, Immunopharmacology.
[62] M. Korbelik,et al. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. , 1999, Cancer letters.
[63] S. Gollnick,et al. Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease , 2014, Cancer Immunology, Immunotherapy.
[64] Yan Xu,et al. Efficacy of antitumoral photodynamic therapy with hypericin: Relationship between biodistribution and photodynamic effects in the RIF‐1 mouse tumor model , 2001, International journal of cancer.
[65] A. Cincotta,et al. Role of the Immune System in Mediating the Antitumor Effect of Benzophenothiazine Photodynamic Therapy , 1999, Photochemistry and photobiology.
[66] P. Agostinis,et al. Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity , 2013, Front. Immunol..
[67] Michael R Hamblin,et al. Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen , 2013, British Journal of Cancer.
[68] S. Sakaguchi,et al. Regulatory T cells in tumor immunity , 2010, International journal of cancer.
[69] S. Mehrotra,et al. Th17 Cells in Cancer: The Ultimate Identity Crisis , 2014, Front. Immunol..
[70] T. Greten,et al. Immunogenicity of necrotic cell death , 2014, Cellular and Molecular Life Sciences.
[71] R. Weissleder,et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo , 2005 .
[72] S. Gollnick,et al. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells , 2007, British Journal of Cancer.
[73] A. Liston,et al. Regulatory T Cells , 2011, Methods in Molecular Biology.
[74] Barbara Owczarczak,et al. Photodynamic therapy and anti‐tumor immunity , 2006, Lasers in surgery and medicine.
[75] S. Gollnick. Photodynamic therapy and antitumor immunity. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[76] S. Endres,et al. Apoptotic Pancreatic Tumor Cells Are Superior to Cell Lysates in Promoting Cross-Priming of Cytotoxic T Cells and Activate NK and γδ T Cells , 2002 .
[77] P. Agostinis,et al. ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses , 2014, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[78] M. Manns,et al. Primary sterile necrotic cells fail to cross-prime CD8+ T cells , 2012, Oncoimmunology.
[79] B W Henderson,et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.
[80] Malini Olivo,et al. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. , 2008, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[81] S. Endres,et al. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. , 2002, Cancer research.
[82] Steffen Jung,et al. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity , 2008, Cancer Immunology, Immunotherapy.
[83] A. Gaitas,et al. Extracorporeal Photo-Immunotherapy for Circulating Tumor Cells , 2015, PloS one.
[84] T. Frankel,et al. Regulatory T Cells in Tumor Immunity , 2016 .
[85] H. Kato,et al. Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy , 2006, Clinical Cancer Research.
[86] Qian Peng,et al. An outline of the hundred-year history of PDT. , 2003, Anticancer research.
[87] F. Ramsdell,et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.
[88] F. Berr,et al. Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.
[89] Martin G. Mack,et al. Interstitial photodynamic laser therapy in interventional oncology , 2004, European Radiology.